A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody, for Advanced Solid Tumors or With mXELOX/XELOX as First-line Therapy for Advanced Gastric or GEJ Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Advanced Solid Tumors
Related studies linked through entity extraction aliases.
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ASP1951 in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)
- Status
- COMPLETED
- Phase
- PHASE2
A Real World Study of Anti-PD-1/PD-L1 Antibodies for the Treatment of Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- N/A
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of CS1001 in Subjects with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Intratumoral/Intralesional Administration of MK-4621/JetPEI™ With or Without Pembrolizumab in Participants With Advanced/Metastatic or Recurrent Solid Tumors (MK-4621-002)
- Status
- TERMINATED
- Phase
- PHASE1
KN046 in Subjects With Advanced Solid Tumors and Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of TP-3654 in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody for Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics, and Antitumor Study of ADCT-601 to Treat Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase 1b Study to Assess Sitravatinib in Combination With Tislelizumab in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Safety of TT-00420 (Tinengotinib) Monotherapy in Patients With Advanced Solid Tumors and Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy Volunteers
- Status
- UNKNOWN
- Phase
- PHASE1
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1 Study of HLX20, a Human Monoclonal Antibody Targeting PD-L1Protein in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1